Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.
O'Tuathaigh CM, Clarke G, Walsh J, Desbonnet L, Petit E, O'Leary C, Tighe O, Clarke N, Karayiorgou M, Gogos JA, Dinan TG, Cryan JF, Waddington JL.
O'Tuathaigh CM, et al. Among authors: desbonnet l.
Int J Neuropsychopharmacol. 2012 Oct;15(9):1331-42. doi: 10.1017/S1461145711001581. Epub 2011 Nov 11.
Int J Neuropsychopharmacol. 2012.
PMID: 22074909
Free article.